| MERCK & CO. INC. |
| USA |
| Gesundheit |
| US58933Y1055 / A0YD8Q |
| 6MK (Frankfurt) / MRK (NYSE) |
| FRA:6MK, ETR:6MK, 6MK:GR, NYSE:MRK |
| https://www.merck.com/ |
|
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals s..
>Volltext.. |
| 245164.23 Mio. EUR |
| 282680.99 Mio. EUR |
| 57104.38 Mio. EUR |
| 21024.37 Mio. EUR |
| 7788.9 Mio. EUR |
| 3.11 EUR |
| 42816.73 Mio. EUR |
| 4705.6 Mio. EUR |
| 15595.24 Mio. EUR |
| 0.21 |
| -3.83% |
| -52.01% |
| 2.89 EUR |
| 2.92% |
| 2.96% |
| 15.06.26 - 0.73338€ 16.03.26 - 0.73703504€ >weitere anzeigen... |
| - |
| MERCK & CO, MERCK&CO, MERCK CO, MERCKCO, MRK |
| 22.06.26 |
|